Articles by Disease (Others)

Patent Selections:

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume: 4
Page: 172-174
Author(s): Bentham Science Publishers

Protein Modification by β-N-Acetyl Glucosamine (O-GlcNAc) in Insulin Signaling and Insulin Resistance

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume: 4
Page: 161-171
Author(s): Sudharsana R. Ande and Suresh Mishra

HDL - Cholesterol: The New Target for Treatment

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume: 4
Page: 153-160
Author(s): Sanjay Kalra, Bharti Kalra, Navneet Agrawal and Ashraf Ganie

Recent Advances in the Development of Novel Therapeutics Targeting Dendritic Cells

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume: 4
Page: 146-152
Author(s): Adriana J. Michielsen, Jacintha N. O'Sullivan and Elizabeth J. Ryan

Asymptomatic Primary Hyperparathyroidism: Management and Implications

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume: 4
Page: 138-145
Author(s): Malgorzata Trofimiuk, Dorota Pach and Alicja Hubalewska-Dydejczyk

Dolichol: A Natural Biomarker of Aging Endowed With a Photoenhanced Highly-Effective Solar Filter Activity

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume: 4
Page: 131-137
Author(s): Ranieri Bizzarri and Ettore Bergamini

Recent Patents in Diagnosis and Treatment for Inborn Errors of Metabolism

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Volume: 4
Page: 111-130
Author(s): Angela J. Espejo, Luis F. Malaver, Alexander Rodriguez, Rocio del P. Cuaspa, Carlos J. Almeciga-Diaz and Luis A. Barrera

‹
1
2
...
1693
1694
1695
1696
1697
1698
1699
...
2397
2398
›